Stocks in Focus

CJ CGV Soars 13% on News of Investment by the National Growth Fund

Kim Kyung-eun
2026-07-30 09:21:04
[Edaily Reporter Kim Kyung-eun ] Shares of CJ CGV(079160)are trading higher in early trading on the 30th following news that the company is receiving an investment from the National Growth Fund.

(Photo = News1)


According to MP Doctor, as of 9:15 a.m. today, CJ CGV is trading at 5,390 won, up 620 won (13.00%) from the previous trading day.

This is interpreted as a result of media reports that CJ 4Dplex, a subsidiary of CJ CGV, is set to receive a large-scale investment from the National Growth Fund, which has boosted investor sentiment.

According to the reports, CJ Corp. 4Dplex is seeking to attract 200 billion won in external investment, and the National Growth Fund is considering a plan to invest by matching funds from the High-Tech Strategic Industry Fund with private capital.

The National Growth Fund is a policy-driven growth fund that will be established with a total scale of 200 trillion won over the next five years. It pools funds from the government and private financial institutions to invest in high-tech industries—such as semiconductors, artificial intelligence (AI), and biotechnology—and related companies.

Economy

Corporation

IT·Science

Economy

From Buildings to Operating Companies… Rental Housing Platforms Swallowed Whole

The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
2026-08-11 00:34:03

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

Medy-Tox Inc. Reports 11% Increase in Second-Quarter Revenue… ‘NewViju’ Emerges as New Growth Engine

Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …
2026-08-10 17:02:01